Time to onset of adverse events
Phase 2/3 Trials in Xydalba clinical trial programme
The distribution of day of onset of adverse events in patients receiving Xydalba was similar to that on the comparator regimens11.
The distribution of day of onset of adverse events in patients receiving Xydalba was similar to that on the comparator regimens11.